NMR structural characterization of peptide inhibitors bound to the hepatitis C virus NS3 protease: Design of a new P2 substituent

被引:51
作者
Goudreau, N [1 ]
Cameron, DR
Bonneau, P
Gorys, V
Plouffe, C
Poirier, M
Lamarre, D
Llinas-Brunet, M
机构
[1] Boehringer Ingelheim Canada Ltd, Res & Dev, Dept Chem, Laval, PQ H7S 2G5, Canada
[2] Boehringer Ingelheim Canada Ltd, Res & Dev, Dept Biol Sci, Laval, PQ H7S 2G5, Canada
关键词
D O I
10.1021/jm0303002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A comparative NMR conformational analysis of three distinct tetrapeptide inhibitors of the Hepatitis C NS3 protease that differ at the 4-aryloxy-substituted P2 proline position was undertaken. Specifically, transferred nuclear Overhauser effect experiments in combination with restrained systematic conformational searches were used to characterize the orientation of the P2 aryl substituents of these inhibitors when bound to the NS3 protease. Differences between free and bound conformations were also investigated. Analysis of the results allowed the design of a new P2 aromatic substituent, which significantly increased the potency of our inhibitors. The bound conformation of a specific competitive inhibitor having this novel P2 substituent is also described, along with a model of this inhibitor bound to the NS3 protease. This NS3 protease/inhibitor complex model also supports a hypothetical stabilization role for the P2 residue of the substrates and/or inhibitors and further elucidates the subtle details of the binding of the P2 residue of substrate-based inhibitors.
引用
收藏
页码:123 / 132
页数:10
相关论文
共 43 条
  • [1] Inhibitor binding induces active site stabilization of the HCVNS3 protein serine protease domain
    Barbato, G
    Cicero, DO
    Cordier, F
    Narjes, F
    Gerlach, B
    Sambucini, S
    Grzesiek, S
    Matassa, VG
    De Francesco, R
    Bazzo, R
    [J]. EMBO JOURNAL, 2000, 19 (06) : 1195 - 1206
  • [2] The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism
    Barbato, G
    Cicero, DO
    Nardi, MC
    Steinkühler, C
    Cortese, R
    De Francesco, R
    Bazzo, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 289 (02) : 371 - 384
  • [3] The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy
    Bartenschlager, R
    [J]. JOURNAL OF VIRAL HEPATITIS, 1999, 6 (03) : 165 - 181
  • [4] Replication of hepatitis C virus
    Bartenschlager, R
    Lohmann, V
    [J]. JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 1631 - 1648
  • [5] CHEN KX, 2001, Patent No. 0177113
  • [6] Choi HK, 1997, PROTEINS, V27, P345, DOI 10.1002/(SICI)1097-0134(199703)27:3<345::AID-PROT3>3.0.CO
  • [7] 2-C
  • [8] STRUCTURE OF SINDBIS VIRUS CORE PROTEIN REVEALS A CHYMOTRYPSIN-LIKE SERINE PROTEINASE AND THE ORGANIZATION OF THE VIRION
    CHOI, HK
    TONG, L
    MINOR, W
    DUMAS, P
    BOEGE, U
    ROSSMANN, MG
    WENGLER, G
    [J]. NATURE, 1991, 354 (6348) : 37 - 43
  • [9] Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies
    Cicero, DO
    Barbato, G
    Koch, U
    Ingallinella, P
    Bianchi, E
    Nardi, MC
    Steinkühler, C
    Cortese, R
    Matassa, V
    De Francesco, R
    Pessi, A
    Bazzo, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 289 (02) : 385 - 396
  • [10] De Francesco R, 2000, CURR TOP MICROBIOL, V242, P149